Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by malibukion Nov 03, 2016 2:42pm

344 Views

Post# 25421430

Update in early December for the rest of the pipeline

Hi Sirona people,

I asked for a birthday gift from Sirona :) about the progress of the rest of the pipeline and got the following note from PR. Confidence level is increased form "very" to "extremely" which sounds good.

BTW Str and Bal thanks for nice wishes. We could organize a birthday party when the deal is announced. :)

----------------e.mail---------------

I cannot provide an individual update, but we are working on an update letter for all shareholders.

This will be in early December and will cover the status of the pipeline.

Of course, any material news will be released immediately to shareholders.

I remain extremely confident in Sirona’s technology and strategy.

Best Regards,

Bullboard Posts

This junior mining stock offers billions in market exposure